Validation of Steroid-Sparing Therapy in Patients Receiving Oxaliplatin-based Chemotherapy: A before-and-after Prospective Observational Study

Volume 26, Issue 10, October 2025, Pages 3623-3628

Yoshihiro Yamamoto; Norio Watanabe; Aoi Goshima; Hiroki Hayashi; Tomohiro Fukuoka; Motozumi Ando; Masami Kawahara

• View Article
• PDF 394.67 K

Efficacy of Olanzapine 5 mg versus 10 mg for the Prophylaxis of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving High Emetic Risk Chemotherapy without Neurokinin-1 Receptor Antagonist

Volume 23, Issue 6, June 2022, Pages 2137-2143

Sitthi Sukauichai; Chaninun Ketkaew; Naparat Othaganont; Pichayapa Pichaya; Pimonwan Promsuwan

• View Article
• PDF 480.66 K

Adherence to ASCO for Prophylaxis of Acute Chemotherapy- Induced Nausea and Vomiting in Iran

Volume 21, Issue 6, June 2020, Pages 1567-1572

Mahbobeh Ebrahimi; Valiollah Mehrzad; Azadeh Moghaddas

• View Article
• PDF 258.06 K

Aprepitant in the Prevention of Vomiting Induced by Moderately and Highly Emetogenic Chemotherapy

Volume 15, Issue 23, December 2014, Pages 10045-10051

• View Article
• PDF 496.09 K

Olanzapine for Preventing Nausea and Vomiting Induced by Moderately and Highly Emetogenic Chemotherapy

Volume 15, Issue 22, December 2014, Pages 9587-9592

• View Article
• PDF 457.28 K